ESOMEPRAZOLE MAGNESIUM | N204655 | ASTRAZENECA LP
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ASTRAZENECA AB et al v. PERRIGO COMPANY PLC et al 2 patentsANDA 207193esomeprazole magnesium | D.N.J. | 2015-02-04 | Terminated 2017-06-09 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Hyman Phelps and McNamara PC FDA-2015-P-2230 · 5 docket documents Hyman, Phelps & McNamara, P.C. submitted this petition pursuant to FDC Act section 505(j)(2)(C) requesting that FDA determine that Esomeprazole Magnesium Delayed-Release Tablets, 20 mg (OTC), is suitable for submission in an ANDA, with the reference listed drug being AstraZeneca's NEXIUM 24HR Delaye | Other | 2015-08-18 | Withdrawn | Hyman Phelps and McNamara PC |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.